File(s) not publicly available
Discovery and Management of Adverse Drug Reactions: The Nomifensine Hypersensitivity Syndrome, 1977-1986
journal contribution
posted on 2023-06-07, 23:18 authored by John Abraham, Courtney DavisTaking the antidepressant, nomifensine, this article focuses on the discovery and management of adverse drug reactions (ADRs) manifested in doctors' spontaneous post-marketing reports. Company-friendly experts, free-lancer research scientists, public servant physicians and regulatory scientists are shown to have made distinct contributions to ADR discovery. However, institutional and international fragmentation delayed synthesis of ADR reports into unambiguous discovery. Qualitative and quantitative interpretative standards of what counted as ADR discovery affected regulatory warning systems and decisions about when to withdraw a drug from the market. The timing and definition of an ADR as `irreversible or `rare was, in part, a function of the uncertainty and estimation criteria chosen by the party managing the discovery. UK regulators accepted relatively low levels of uncertainty, so the timing of discovery, warnings and regulatory action was relatively late, but US regulators chose higher thresholds of uncertainty about discovery when interpreting the need to warn of suspected serious ADRs. The implications of these practices for the founding ideals of a post-marketing `early warning system are considered.
History
Publication status
- Published
Journal
Social History of MedicineISSN
0951-631XExternal DOI
Issue
1Volume
23Page range
153-173Pages
21.0Department affiliated with
- Sociology and Criminology Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2012-02-06Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC